Intellectual Property

Life Sciences, Chemicals & Materials

Knowledge driven, 360° strategic counsel to make the most of your science and technology

Cohen & Grigsby has extensive experience serving life science, chemical and material companies in all stages of development — from start-ups to Fortune 500 companies. Our understanding of the science and technology at the heart of your business is the foundation for how we help you convert ideas into opportunities that optimize your potential.

Our lawyers provide strategic, knowledge-driven counsel aligned with clients’ objectives. We not only serve as trusted legal advisors, but also as trusted business counselors dedicated to delivering results and providing responsive and attentive service geared toward making the most of your opportunities and mitigating your liabilities.

From entity formation to corporate governance, business transactions, procurement, protection and commercialization of your intellectual property, and import/export, tax, product-liability, and litigation matters, we bring the strength of our multi-disciplinary, strategic legal and business approach to fulfilling your company’s business objectives.

Legal & Technical Expertise to Deliver Results

Combining our legal knowledge with our technical experience enables us to understand and respond to the unique legal problems and business cycles that biotechnology, chemical, healthcare, life science, medical device and pharmaceutical companies face. Our lawyers come from a variety of legal backgrounds, such as corporate, environmental, intellectual property, litigation, and labor and employment, and others have substantial industry experience prior to their legal careers or earned advanced degrees in biology or chemistry. Our team has experience in the following areas of life science, chemical and material technologies:

  • Adhesives, coatings, films, and sealants
  • Analytical chemistry
  • Agricultural products
  • Biochemistry and biophysics
  • Biomaterials
  • Biotechnology
  • Ceramics
  • Computational and structural biology
  • Cosmetics
  • Dietary supplements
  • Drug delivery
  • Energy
  • Environmental science
  • Food science
  • Green technology
  • Laboratory instrumentation
  • Material science
  • Medical devices
  • Molecular and cellular biology
  • Nanotechnology
  • Organic chemistry
  • Oncology
  • Pharmaceuticals
  • Polymers
  • Proteomics
  • Water treatment

How Can We Help You?

  • Company formation & capitalization
  • Public and private equity and debt financings
  • Research and development financings
  • Securities
  • Corporate governance
  • Mergers and Acquisitions
  • University technology transfer
  • Intellectual property procurement, management and enforcement – copyrights, patents, trademarks and trade secrets
  • IP opinions on patentability, validity, freedom to operate and patent infringement
  • IP transactions and licensing
  • IP audits, due diligence and valuation
  • Joint research and development ventures and strategic alliances

Several examples illustrate how we have provided legal counsel to help clients in the life science, chemical and material industries make the most of their business opportunities:

  • Drafted and negotiated a joint research and development agreement between a biotechnology company and a global pharmaceutical company
  • Drafted and negotiated manufacture, supply and distribution agreements between a chemical manufacturer and a distributor
  • Drafted and negotiated a joint research and development agreement between national laboratories and an equipment manufacturer
  • Drafted license, supply and clinical trial agreement between a global pharmaceutical company and a private label manufacturer
  • Negotiated license, development and commercialization agreement between a university and a start-up bioanalytics company
  • Prepared and prosecuted biotechnology patent applications in the field of peptide and nucleotide products and structural mimics, small molecule drugs, skin substitutes, and insulin testing devices and methods
  • Obtained patent protection and licensing rights for medical device companies in the development of catheters, stents, orthopedic devices and implantable devices for drug delivery
  • Prepared and prosecuted patent applications for cancer diagnostic devices and methods of healthcare company
  • Prepare and prosecuted chemical and material patent applications in the field of polymers and polymerization processes, industrial chemicals, foams, resins, coatings, adhesives, sealants, ceramics, metal alloys, surface analysis devices and methods, mass spectrometry, separation processes lab-on-a-chip and microfluidics
  • Counseled global chemical company on product clearance and invalidity
  • Counseled global medical device company on product clearance and alternative product development of medical implant
  • Counseled global food and beverage company on product clearance and alternative product development
  • Counseled global biotechnology and chemical companies in due diligence associated with business merger and intellectual property acquisitions
  • Counseled companies on strategic planning of intellectual property portfolio development, licensing, defense, and enforcement
  • Counseled start-up company on branding strategies, selection of a trademark or design, and conducted trademark availability searches and analysis
  • Counseled start-up companies and global corporations in both inbound and outbound patent and trademark prosecution and enforcement
  • Assisted a leading innovative healthcare company negotiate an agreement with a leading pharmaceutical company to provide for the parties’ conversion of a prescription drug formulation into an over-the-counter drug formulation in the United States
  • Assisted international research and development client in the acquisition of prescription acne product lines (in various formulations) by negotiating the purchase agreement and counseling the client in all aspects of the transaction
  • Assisted a large self-test diagnostic business acquire, through merger, a privately held manufacturer and marketer of a meter-based diabetes monitoring system and counseled in the related buyout of the target company’s various classes of shareholders